ELTEK LTD.
|
|
(Registrant)
|
|
By: /s/ Ron Freund
|
|
Ron Freund
|
|
Chief Financial Officer
|
EXHIBIT NO.
|
|
DESCRIPTION
|
|
|
|
◾ |
Revenues were $11.5 million, 18% up over Q1 2022
|
◾ |
Operating profit was $1.6 million, 144% up over Q1 2022
|
◾ |
Profit before tax was $1.9 million (2022 Q1 - $0.8 million)
|
◾ |
Net income was $1.6 million or $0.27 per fully diluted share, 147% up over Q1 2022
|
◾ |
Net cash provided by operating activities amounted to $2.8 million
|
United States:
|
1-866-860-9642 |
Israel: |
03-918-0691 |
International: |
+972-3-918-0691 |
Three months ended
|
||||||||
March 31,
|
||||||||
2023
|
2022
|
|||||||
Revenues
|
11,470
|
9,755
|
||||||
Costs of revenues
|
(8,455
|
)
|
(7,794
|
)
|
||||
Gross profit
|
3,015
|
1,961
|
||||||
Selling, general and administrative expenses
|
(1,417
|
)
|
(1,293
|
)
|
||||
R&D expenses, net
|
(9
|
)
|
(17
|
)
|
||||
Operating profit
|
1,589
|
651
|
||||||
Financial income, net
|
287
|
121
|
||||||
Profit before income tax
|
1,876
|
772
|
||||||
Tax expenses
|
314
|
140
|
||||||
Net Income
|
1,562
|
632
|
||||||
Earnings per share:
|
||||||||
Basic net income per ordinary share
|
0.27
|
0.11
|
||||||
Diluted net income per ordinary share
|
0.27
|
0.11
|
||||||
Weighted average number of ordinary shares used to compute
|
||||||||
basic net income per ordinary share (in thousands)
|
5,850
|
5,843
|
||||||
Weighted average number of ordinary shares used to compute
|
||||||||
diluted net income per ordinary share (in thousands)
|
5,852
|
5,843
|
March 31,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
8,059
|
7,366
|
||||||
Receivables: Trade, net of provision for doubtful accounts
|
9,761
|
10,116
|
||||||
Other
|
675
|
282
|
||||||
Inventories
|
5,307
|
5,130
|
||||||
Prepaid expenses
|
615
|
504
|
||||||
Total current assets
|
24,417
|
23,398
|
||||||
Long term assets:
|
||||||||
Restricted deposits
|
198
|
202
|
||||||
Severance pay fund
|
57
|
59
|
||||||
Deferred tax assets and long term tax receivables, net
|
2,124
|
2,496
|
||||||
Operating lease right of use assets
|
7,050
|
7,693
|
||||||
Total long term assets
|
9,429
|
10,450
|
||||||
Fixed assets, less accumulated depreciation
|
7,345
|
7,674
|
||||||
Total Assets
|
41,191
|
41,522
|
||||||
Liabilities and Shareholder's equity
|
||||||||
Current liabilities:
|
||||||||
Short-term credit and current maturities of long-term debts
|
281
|
702
|
||||||
Accounts payable: Trade
|
4,977
|
4,793
|
||||||
Other
|
4,871
|
4,133
|
||||||
Short-term operating lease liabilities
|
849
|
846
|
||||||
Total current liabilities
|
10,978
|
10,474
|
||||||
Long-term liabilities:
|
||||||||
Long term debt, excluding current maturities
|
1,565
|
2,768
|
||||||
Employee severance benefits
|
278
|
280
|
||||||
Long-term operating lease liabilities
|
6,297
|
6,980
|
||||||
Total long-term liabilities
|
8,140
|
10,028
|
||||||
Shareholders' equity:
|
||||||||
Ordinary shares, NIS 3.0 par value authorized 10,000,000 shares, issued
and outstanding 5,849,678 at March 31, 2023 and December 31, 2022
|
5,305
|
5,305
|
||||||
Additional paid-in capital
|
22,862
|
22,862
|
||||||
Cumulative foreign currency translation adjustments
|
608
|
1,189
|
||||||
Capital reserve
|
1,609
|
1,537
|
||||||
Accumulated deficit
|
(8,311
|
)
|
(9,873
|
)
|
||||
Total shareholders' equity
|
22,073
|
21,020
|
||||||
Total liabilities and shareholders' equity
|
41,191
|
41,522
|
Three months ended
|
||||||||
March 31,
|
||||||||
2023
|
2022
|
|||||||
GAAP net Income
|
1,562
|
632
|
||||||
Add back items:
|
||||||||
Financial income, net
|
(287
|
)
|
(121
|
)
|
||||
Income tax expenses
|
314
|
140
|
||||||
Depreciation and amortization
|
329
|
435
|
||||||
Non-GAAP EBITDA
|
1,918
|
1,086
|
Three months ended
|
||||||||
March 31,
|
||||||||
2023
|
2022
|
|||||||
Cash flows from operating activities:
|
||||||||
Net Income
|
1,562
|
632
|
||||||
Adjustments to reconcile net income to net cash flows
|
||||||||
provided by operating activities:
|
||||||||
Depreciation and amortization
|
329
|
435
|
||||||
Stock-based compensation
|
72
|
53
|
||||||
Decrease in deferred tax assets and long term tax receivable
|
306
|
140
|
||||||
707
|
628
|
|||||||
Decrease (increase) in operating lease right-of-use assets
|
(33
|
)
|
4
|
|||||
Decrease (increase) in trade receivables
|
112
|
(1,160
|
)
|
|||||
Decrease (increase) in other receivables and prepaid expenses
|
(525
|
)
|
(82
|
)
|
||||
Decrease (increase) in inventories
|
(313
|
)
|
(674
|
)
|
||||
Increase (decrease) in trade payables
|
412
|
485
|
||||||
Increase (decrease) in other liabilities and accrued expenses
|
847
|
506
|
||||||
Increase (decrease) in employee severance benefits, net
|
5
|
2
|
||||||
505
|
(919
|
)
|
||||||
Net cash provided by operating activities
|
2,774
|
341
|
||||||
Cash flows from investing activities:
|
||||||||
Purchase of fixed assets
|
(305
|
)
|
(289
|
)
|
||||
Net cash used in investing activities
|
(305
|
)
|
(289
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Exercise of options
|
-
|
25
|
||||||
Repayment of long-term loans from bank
|
(1,580
|
)
|
(114
|
)
|
||||
Repayment of credit from fixed asset payables
|
-
|
(3
|
)
|
|||||
Net cash used in financing activities
|
(1,580
|
)
|
(92
|
)
|
||||
Effect of translation adjustments
|
(196
|
)
|
(189
|
)
|
||||
Net increase (decrease) in cash and cash equivalents
|
693
|
(229
|
)
|
|||||
Cash and cash equivalents at the beginning of the period
|
7,366
|
9,283
|
||||||
Cash and cash equivalents at the end of the period
|
8,059
|
9,054
|
CV\!?6('JN:*\I7XAS'UIZ_$&4GO1[> /$0[GJ=)7FT?
MCMV'6K4/C0OU-'UB >WAW/0!2UR$'BA9,9YR!@T9-+N[4E'00=:,8I0<4$Y
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M+4'6-#2L1UI"O-(1@4O:,KVC#=D<]:%QWH"@C-"C/6AS
M8O:,.,T'&>*/XL4,N.E'.P]HQV\@<4"XE'\5-(PN:51D4*;L/VK'K>W"]'-2
M#5+Q.1(:K]Z!SQ1[1C51EQ->O@1^];\ZVK#Q3,A DD/YUS+1@=*9Y8ZYK2-=
MFJKON>J:?XS@11YC_K6Y:>+K.X8*K#/UKQ$ X^\:GM+Q[23
+'C()KUKPUH26T:N4QD5TTJ5V=U"BY,ET+PVEK$I91Q7510K&N
MH%+&@1<"I*]:$$D>S""BA,4 8I:*T- INWG-.HH **** "BBB@!"*0J#UIU%
M*PK&5JFFQWELT>P9/M7DOB7P^VF2%E!.37MI%8.NZ3'>PL67) KFKTTT E+@8]Z2!NXP#%+3J0<'FJL/8,T4'D
M\4O&*=Q*5Q-W&*%XI,CI3EP.M2-Q(W'>ND\,WWD2JN< 6T*V&&148?G%.4\
M<4(J[JE$H7C%&0.M.8#M30 >M5T!["Y'6D/S=*.,XH^[TK,A1#VI<44"M$:H
M!R<&E,/\0IIXH\QNG:HEHR&@,@Z4TCEX4<40J-#C-Q80W-S:N")
M"!77:1XR%GM$KYQZFN1&&'S5"T"DUUPQ%CKABK'LUAXUM[O !%=%;ZA'<*"&
M'-?/\%S):
MXCWJ$O<0ZBBBMC<**** "BBB@ HHHH Y3QES9GZ5X_>$"4BO7_&7%F?I7D%X
M 92:\W&;GDX[<@4XH)I**\U'E!WIV1BFBBF F<4X&E !'-)WHN"W#OF@MGI1
MWQ2D =*2![C:E."@=*Y+N
M]CDN,_BQ3F7 IIZTX-GK6ERUL-I>M(>M'>EBG:P6&^]/#9XI*#@=*F3): MVI =M''XT
M$4UL/EL@)I5&1FFCKS4HQCBBXF[# :7-%F5J%+BD )/%./ II
MC$Q2;:%SGFEYS3*Y4+BDQGBD;)Z4 ''%/H2UH!&WBE48YI#QUIH)S6